| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |